Select Language
Free Registration

TGF-beta RI

TGF-beta RI Overview

English NameTransforming growth factor beta receptor 1Approved Drugs0
Drugs in Clinical Trials7Target SynonymEC 2.7.11，TGF-beta type I receptor，Serine/threonine-protein kinase receptor R4，TGFBR1，Activin A receptor type II-like protein kinase of 53kD，Transforming Growth Factor Beta Receptor 1，Transforming Growth Factor-Beta Receptor Type I，Activin A Receptor Type II-Like Kinase， 53kDa，Activin Receptor-Like Kinase 5，TGFR-1，ALK-5，ALK5，SKR4，Mutant Transforming Growth Factor Beta Receptor I，TGF-Beta Receptor Type-1，TGF-Beta Receptor Type I，EC 2.7.11.30，ACVRLK4，LDS1A，LDS2A，AAT5，LDS1，TBRI，ESS1，MSSE，TbetaR-I，Transforming Growth Factor Beta Receptor I，Multiple Self-Healing Squamous Epithelioma，TBR-I，Receptor， Transforming Growth Factor-beta Type I，EC:2.7.11.30
Highest Development StagePhase 3 Clinical
English NameTransforming growth factor beta receptor 1
Target SynonymEC 2.7.11，TGF-beta type I receptor，Serine/threonine-protein kinase receptor R4，TGFBR1，Activin A receptor type II-like protein kinase of 53kD，Transforming Growth Factor Beta Receptor 1，Transforming Growth Factor-Beta Receptor Type I，Activin A Receptor Type II-Like Kinase， 53kDa，Activin Receptor-Like Kinase 5，TGFR-1，ALK-5，ALK5，SKR4，Mutant Transforming Growth Factor Beta Receptor I，TGF-Beta Receptor Type-1，TGF-Beta Receptor Type I，EC 2.7.11.30，ACVRLK4，LDS1A，LDS2A，AAT5，LDS1，TBRI，ESS1，MSSE，TbetaR-I，Transforming Growth Factor Beta Receptor I，Multiple Self-Healing Squamous Epithelioma，TBR-I，Receptor， Transforming Growth Factor-beta Type I，EC:2.7.11.30
Approved Drugs0
Drugs in Clinical Trials7
Highest Development StagePhase 3 Clinical

TGF-beta RI Product List

  • Product Category

    Protein (2)

  • Product Status

    Launched (2)

  • Species

    Human (2)

  • Tag

    Llama IgG Fc Tag (1)Fc Tag (1)

  • Conjugate

    Unconjugated (2)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
TG1-H5254
Human
HEK293
Human TGF-beta RI Protein, Fc Tag, low endotoxin (MALS verified)
TG1-H5259
Human
HEK293
Human TGFR-1 / ALK-5 / TGF-beta receptor type-1 Protein, Llama IgG2b Fc Tag (SPR verified)
Total: 2
  • 1

TGF-beta RI Background

TGF type I receptor also called the activin receptor-like kinase 5 (ALK5) and involved in TGF signaling. TGFβ signaling is mediated by the interaction of TGFβ ligands (TGFβ 1, 2 or 3) with cell surface receptors, the TGF type I, type II and type III receptors. Signaling is initiated by binding of TGF to the TGF type II receptor forming a ligand-receptor complex which interacts with the TGF type I receptor.

TGF-beta RI Synonyms

TGFR-1, ALK-5, TGF-beta receptor type-1, Activin receptor-like kinase 5

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
GalunisertibLY-2157299Phase 3 ClinicalEli Lilly And CompanyAmyotrophic Lateral Sclerosis; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Glioblastoma; Glioma; Liver Neoplasms; Metastatic breast cancer; Myelodysplastic Syndromes; Nasopharyngeal Carcinoma; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms; Rectal Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
Details
GF-101GFH-018; GF-101; GFH018Phase 2 ClinicalGenfleet Therapeutics (Shanghai) Co LtdCarcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Liver Neoplasms; Pancreatic Neoplasms; Solid tumours
Details
Tosposertib phosphateTU-2218; NCE401; NCE-401Phase 2 ClinicalTiumBio Co LtdIdiopathic Pulmonary Fibrosis; Solid tumours
Details
OntunisertibORG-129; AGMB-129Phase 2 ClinicalOrigo Biopharma Sociedad LitmitadaCrohn Disease
Details
TRK-250TRK-250; BNC-1021Phase 1 ClinicalBonac CorpIdiopathic Pulmonary Fibrosis
Details
OxinsetiSH-3051Phase 1 ClinicalNanjing Sanhome Pharmaceutical Co Ltd Liver Neoplasms; Solid tumours
Details
AGMB-447AGMB-447; ORG-447Phase 1 ClinicalAgomAb Therapeutics NVIdiopathic Pulmonary Fibrosis
Details
  • Overview
  • Product List
  • Clinical Drug Information
Share to:

Join UsLegalSite MapPrivacy PolicyTerms and Conditions
Website Feedback
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

order@acrobiosystems.com

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland